External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.
CONCLUSION: This study validated the EORTC prognostic model for recurrence-free and melanoma-specific survival of patients with negative sentinel nodes. The addition of other prognostic factors only improved the model marginally. The validated EORTC model could be used for personalizing follow-up and selecting high-risk patients for trials of adjuvant systemic therapy.
PMID: 31310333 [PubMed - as supplied by publisher]
Source: The British Journal of Surgery - Category: Surgery Authors: Ipenburg NA, Nieweg OE, Ahmed T, van Doorn R, Scolyer RA, Long GV, Thompson JF, Lo S Tags: Br J Surg Source Type: research